Recent News News Blog Press Releases In the News Featured News Publications Contact Us Blog Post Oct. 23, 2020 National Institutes of Health Funding Powers Wistar Science in 202... Approaching the end of the year, Wistar takes stock of its federal funding performance. Press Release Oct. 13, 2020 Advancement of Anticancer Compounds for B Cell Cancer Therapy IRE-1 inhibitors block a main pathway in the endoplasmic reticulum stress response that supports cell survival under stressful conditions and is important for B cell cancer development. Blog Post Oct. 8, 2020 A Life at the Intersection of Music, Biotechnology and Business A conversation with Anne Schoemaker about her vision to sponsor The Wistar-Schoemaker International Postdoctoral Fellowship, a partnership launched in 2019 by Wistar and Leiden University Medical… Press Release Sep. 30, 2020 New Mechanism of Cell Survival in Chronic Lymphocytic Leukemia Role of STING signaling in normal B cell differentiation suggests that reduced STING expression and activation promotes malignant cell survival through increased B cell receptor signaling. Featured News Sep. 21, 2020 Women & Science: Developing Immunotherapies for Emerging Patho... Wistar’s first Women & Science event of the COVID-19 era took place virtually and, appropriately, featured Dr. Ami Patel, a Wistar scientist that is playing a major role in the work being done… Press Release Sep. 14, 2020 Wistar Appoints Ami Patel, Ph.D., as Caspar Wistar Fellow Caspar Wistar Fellowship launches the careers of up-and-coming biomedical researchers as top scientific leaders. Press Release Sep. 10, 2020 DNA-based Nanotechnology Stimulates Potent Antitumor Responses Synthetic DNA nanovaccines enhance killer T cell immunity resulting in tumor control in preclinical studies. Press Release Sep. 7, 2020 The BEAT-HIV Martin Delaney Collaboratory Issues Recommendations ... The consortium provides first authoritative viewpoint on which viral measurements to prioritize when evaluating the impact of potential therapeutic strategies to eradicate HIV. Blog Post Aug. 24, 2020 Wistar Science Highlights: New Discoveries on HIV Latency and How ... The sugar molecules on the surface of host cells impact HIV persistency during antiretroviral therapy; breast cancer cells send oncogenic messages to neighboring normal cells using tiny packages… Blog Post Aug. 24, 2020 Scientists Use Knowledge From Traditional Medicine to Discover Dru... Dr. Ian Tietjen came to Wistar in 2019 as a research assistant professor in the laboratory of Dr. Luis Montaner. Press Release Aug. 10, 2020 Breast Cancer Cells Use Message-carrying Vesicles to Send Stimuli Pro-tumorigenic messages reprogram mitochondrial function in normal cells to promote migration and invasion. Press Release Aug. 4, 2020 New Sugar-based Signature Identifies T Cells Where HIV Hides and P... A newly identified sugar signature of T cells infected with HIV despite antiretroviral therapy may deepen our understanding of the cellular processes governing HIV latency, which is critical for… Communications In the News Check out some of the recent media coverage Wistar and its scientists have received. Publications View our Annual Report, Focus magazine and sign-up for our monthly e-newsletter. Media Inquiries If you are a member of the media and would like to speak with a Wistar scientists on any matter, please contact our Communications and Marketing Department.
